{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q38424",
      "entity_text" : "ALT",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00120",
      "entity_text" : "n-3 LC-PUFA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Despite the limited number of studies conducted specifically in children with NAFLD, it is clear from the sensitivity analyses reported herein that n-3 LC-PUFA supplementation in children significantly reduces serum ALT, steatosis score, triglycerides, and HOMA-IR.",
  "reading_complete" : "2020-08-03T10:44:05Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T10:41:25Z",
  "trigger" : "reduces",
  "evidence" : [ "n-3 LC-PUFA supplementation in children significantly reduces serum ALT" ],
  "pmc_id" : "6367993",
  "score" : 0
}